Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
C A Lamb
Observed name:
Christopher A Lamb
Institutions:
Newcastle upon Tyne Hospitals NHS Foundation Trust,
NIHR Newcastle Biomedical Research Centre,
Newcastle University
Observed institutions:
Newcastle upon Tyne Hospitals NHS Foundation Trust,
NIHR Newcastle Biomedical Research Centre,
Newcastle University
ORCID:
0000-0002-7271-4956
Observed ORCID:
0000-0002-7271-4956
OpenAlex ID:
A5123498426
Recent advances in our understanding of the gut microbiome: an analysis from the Gut Microbiota for Health Expert Panel of the British Society of Gastroenterology
2026
·
James L Alexander
, Benjamin H Mullish
, et al.
·
Gut
·
6
OP22 Antibody decay, T cell immunity and breakthrough infections following SARS-CoV-2 vaccination in infliximab- and vedolizumab-treated patients
2022
·
S Lin
, N A Kennedy
, et al.
·
Journal of Crohn s and Colitis
·
3
P0070 Improvement in quality of life in inflammatory bowel disease patients treated with advanced therapies: Interim findings from IBD-RESPONSE
2026
·
H Watson
, L Beck
, et al.
·
Journal of Crohn s and Colitis
P1045 The impact of patient and public involvement and engagement (PPIE) on the design and operationalisation of a multi-centre inception cohort study: Insights from Open-IBD
2026
·
K Jacques
, R Mulligan
, et al.
·
Journal of Crohn s and Colitis
P0056 The gastrointestinal microbiome is associated with endoscopic disease activity in newly-diagnosed Crohn’s Disease: Results from the PROFILE trial
2026
·
G Young
, N Noor
, et al.
·
Journal of Crohn s and Colitis
DOP087 Determining the care quality perception gap between patients and service providers: Comparative analysis of 2019 and 2023 UK IBD benchmarking data from more than 26,000 adult patients and 154 IBD services
2026
·
A B Hawthorne
, P Christiansen
, et al.
·
Journal of Crohn s and Colitis
PDF
P0068 Clinical, demographic and technical drivers of the IBD microbiome: an interim baseline analysis of the IBD-RESPONSE study
2026
·
U Khan
, G Young
, et al.
·
Journal of Crohn s and Colitis
P0063 Colonic imaging mass cytometry and tissue transcriptomics reveal B cell and plasma cell modulation as a key immune feature of response to the anti-integrin therapy etrolizumab in ulcerative colitis
2026
·
J Doyle
, F Tambourini
, et al.
·
Journal of Crohn s and Colitis
P0545 The clinical characteristics of patients with Crohn’s disease and orofacial granulomatosis; high rates or perianal and oesophageal involvement
2026
·
R Lees
, A Molinillo Marin
, et al.
·
Journal of Crohn s and Colitis
P0184 Improvement in fatigue but not joint pain and stiffness in Inflammatory Bowel Disease patients treated with advanced therapies: Interim findings from IBD-RESPONSE
2026
·
L Beck
, H Watson
, et al.
·
Journal of Crohn s and Colitis
P1168 Assessing the impact of a combined Inflammatory Bowel Disease-Rheumatology Clinic: A four-year retrospective service evaluation
2026
·
R Mulligan
, J A Stanway
, et al.
·
Journal of Crohn s and Colitis
PDF
P002 Methodological development of single-cell phenotyping and spatial analysis of intestinal leukocyte, stromal and epithelial cell populations in inflammatory bowel disease formalin fixed paraffin embedded tissue by Hyperion imaging mass cytometry
2021
·
C A Lamb
, J Doyle
, et al.
·
Journal of Crohn s and Colitis
PDF
Show more works
View as search
Works count:
12
Citation count:
9
H-index:
2
I10-index:
Year
Topic
Type